Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
EI-001 antibody treatment for nonsegmental vitiligo
Official title: A Phase 2, Randomized, Double-Blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of EI-001 in Patients With Nonsegmental Vitiligo
Status: Recruiting now
Description:
Elixiron Immunotherapeutics (Hong Kong) Ltd. plans to enroll about 45 participants. EI-001 is an experimental antibody that blocks interferon-gamma, an inflammatory signal involved in melanocyte damage. Researchers hope it will protect pigment-producing cells and support repigmentation. Possible risks include infusion or allergic reactions, headache, and infections; its full safety profile is not yet known. People ages 18 to 65 may qualify. The study is recruiting at 6 listed sites in United States, and Taiwan.
Start date: December 30, 2025
Completion date: September 30, 2027
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Contact: Matthew Campos Site Coordinator
Tel.: 714-375-5970
Email: mcampos@marvelclinical.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How can I cure vitiligo?
Right now, there is no universal "cure," but we have entered a new era of treatment. Today, managing vitiligo isn’t just about "hiding" it; it’s about sophisticated science that...
- Can Ayurveda help with vitiligo?
Ayurveda, the ancient Indian system of holistic medicine, focuses on balancing body energies (Doshas) and improving digestion. While it offers a valuable perspective on "whole-b...
- Diabetes and Vitiligo: Is There a Connection?
Yes, there appears to be a real connection between vitiligo and diabetes, especially type 1 diabetes. A recent study using UK Biobank data also found an association with type 2 ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.